Titan Biotech (BOM:524717) ROCE % : 33.63% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Titan Biotech's annualized ROCE % for the quarter that ended in Dec. 2023 was 33.63%.

Titan Biotech ROCE % Historical Data

The historical data trend for Titan Biotech's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech ROCE % Chart

Titan Biotech Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

16.28

23.84

64.48

39.56

24.85

Titan Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															14.08	23.17	25.83	27.71	33.63

Titan Biotech ROCE % Calculation

Titan Biotech's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	288.62	/	( ( (1433.988 - 252.285)	+	(1345.151 - 203.505) )	/ 2 )
	=	288.62	/	( (1181.703	+	1141.646)	/ 2 )
	=	288.62	/	1161.6745
	=	24.85 %

Titan Biotech's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	408.168	/	( ( (1427.288 - 213.763)	+	(0 - 0) )	/ 1 )
	=	408.168	/	( ( 1213.525	+	0 )	/ 1 )
	=	408.168	/	1213.525
	=	33.63 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Titan Biotech (BOM:524717) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Titan Biotech ROCE % Related Terms

Thank you for viewing the detailed overview of Titan Biotech's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Titan Biotech (BOM:524717) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034

Website

https://www.titanbiotechltd.com

Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech (BOM:524717) Headlines

No Headlines